Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2009Hematology

Standard therapy of advanced Hodgkin lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJohn KuruvillaUniversity of Toronto

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

John Kuruvilla (2009) studied this question.

synapsesocial.com/papers/6a6501f26322f1f8768811e8https://doi.org/10.1182/asheducation-2009.1.497
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-Term Follow-up of Hodgkin's Disease Trial2002 · 138 citations
  2. 2Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial2003 · 486 citations
  3. 3Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease2003 · 840 citations
  4. 4Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)2007 · 128 citations
  5. 5Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin’s Lymphoma Study Group2005 · 298 citations